← Back to Dashboard
Share:
QuantLogix
Quantitative Intelligence
WEEKLY MARKET BRIEFING
April 27 – May 1, 2026
Published: May 1, 2026
Week in Review · W18 / 2026

April closes with a roar as AI capex and Apple's print push the Nasdaq through 25,000 for the first time.

The Nasdaq Composite secured a fresh record close above 25,114 on Friday, capping the strongest monthly gain for U.S. equities since 2020 even as a divided FOMC kept policy on hold and core PCE reaccelerated to 3.5%. Apple's record fiscal Q2 — iPhone revenue at an all-time high and gross margin pushing 49.3% — absorbed mixed reactions from Microsoft, Meta and Amazon, while Alphabet's raised AI capex guide reignited the picks-and-shovels trade. Beneath the surface, stagflation chatter built: GDP rebounded to 2.0% but Q1 PCE printed 4.5%, energy held near $105 WTI on Strait of Hormuz risk, and a record-low Michigan sentiment read sat uneasily next to a 1969-low in jobless claims.

Major Indices & Cross-Asset Snapshot

S&P 500
7,230
+1.0% W · +10.4% MTD
Nasdaq Comp.
25,114
Record Close · +15.6% MTD (NDX)
Dow Industrials
49,499
+7.1% MTD · Best Since Nov '24
VIX
17.05
Off Mid-Week Spike Toward 20
10Y Treasury
4.40%
Tested 4.45% · 9-Mo High
Fed Funds
3.50–3.75%
Held 8–4 · Most Dissents Since '92
WTI Crude
$105.20
Hormuz Risk Premium Sticky
Gold
$4,571
−1.1% D · +41% YoY

Daily Tape — Key Movers This Week

Ticker Name Theme Weekly Catalyst
GOOGL Alphabet Mega-Cap · AI Cloud +6.0% Beat · Raised AI capex
AAPL Apple Hardware · Services +3.0% Record iPhone · Services +16%
MSFT Microsoft Mega-Cap · Copilot −3.0% Beat · Capex digestion
AMZN Amazon Cloud · Retail −3.0% AWS growth in-line
META Meta Platforms AI Capex · Ads −5.0% Flat Q2 revenue guide
RGNX Regeneron Biotech · Gene Therapy Outperform First-ever hearing-loss approval
LMT Lockheed Martin Defense Primes −6.3% Q1 EPS / revenue miss
MRK Merck Pharma Underperform Loss on Cidara M&A charge

Macroeconomic Backdrop

The week pivoted on three crosswinds: a Federal Reserve unwilling to ease into still-hot inflation, a labor market that refuses to crack, and an energy complex tethered to the Strait of Hormuz. The tape rewarded growth and absorbed the friction with surprising composure.

// Monetary Policy

The FOMC held the target range at 3.50–3.75% on April 29 in an 8–4 split — the most dissents since 1992. Governor Stephen Miran favored a 25 bp cut; Hammack, Kashkari and Logan opposed an easing bias in the statement. Powell signaled he intends to stay on as a Fed governor after his chairmanship ends May 15. Fed funds futures still price the next cut for September.

// Growth & Inflation

BEA's advance Q1 2026 GDP came in at +2.0% annualized, a clean rebound from Q4 2025's near-stall +0.5% but a touch under the 2.2% consensus. The mix was decisive: AI-led business investment rose +8.7% while the headline PCE deflator jumped +4.5% for the quarter. March core PCE accelerated to 3.5% YoY, an uncomfortable read for a Fed already on hold.

// Labor & Sentiment

Initial jobless claims printed 189,000 for the week ended April 25 — the lowest since 1969. March nonfarm payrolls (+178k) and a 4.3% unemployment rate remain the policy anchor. Yet the University of Michigan consumer sentiment index hovered near record lows on fuel and tariff anxiety, evidence of a widening split between hard and soft data.

// Geopolitics & Energy

The U.S.–Iran impasse and effective closure of the Strait of Hormuz kept WTI anchored near $105 and Brent near $108, with the IEA terming it an unprecedented supply shock. The dollar held a bid, gold consolidated near $4,571 after a parabolic April, and the 10Y briefly tagged 4.45% before settling at 4.40%.

QuantLogix Read
Real growth re-accelerating into a 4-handle inflation print is the textbook stagflation tilt — and yet equity multiples expanded. The market is paying for AI productivity as if it can outrun both energy and the deflator. That bet looked correct in April; it now needs payrolls (May 8) and ISM Services to confirm the soft data is wrong, not the hard data.

Industry Deep Dive

Technology
Bullish

Mega-cap earnings cleared the bar. Apple printed fiscal Q2 revenue of $111.2B with EPS of $2.01 (vs. $1.95 est.), iPhone at an all-time high of $85.3B and Services at a record $30.98B (+16% YoY). Greater China revenue snapped back to $20.5B (+28% YoY) and gross margin lifted to 49.3%. Tim Cook will hand the CEO seat to hardware chief John Ternus on September 1.

  • AAPL +3% on better-than-expected revenue guidance for the current quarter
  • MSFT −3% post-print — beat, but capex intensity weighed
  • AMZN −3% on AWS growth merely matching the AI bar
  • NDX +15.6% MTD — April was the strongest tech month since 2020
Artificial Intelligence
Bullish

The week's tell was Alphabet: a beat on the top and bottom lines plus a raised AI infrastructure capex guide sent shares up as much as +6% after-hours, reanimating the foundry/networking/power complex. Meta faded −5% on a flat Q2 revenue guide, a reminder that AI capex is being scrutinized for monetization velocity, not just scale.

  • GOOGL +6% AH · raised data-center spend guide
  • NVDA Q1 FY27 revenue guide $78B (+14.5% q/q), data-center +68% YoY
  • TSM +26% YTD · foundry value capture remains the bottleneck
  • AMD reports next week · MI450 & Meta/OpenAI deals in focus
Defense & Aerospace
Bifurcated

The Q1 print was a tale of execution. RTX beat (EPS $1.78 vs. $1.52; revenue $22.1B vs. $21.45B est.) and raised FY26 EPS guidance to $6.70–$6.90. Northrop Grumman beat on both lines (EPS $6.14 / revenue $9.9B) on what CEO Kathy Warden called “unprecedented global demand.” Lockheed Martin missed and traded −6.3% on the day.

  • RTX guidance raise · FY26 EPS $6.70–$6.90
  • NOC +29% YTD · $95.7B backlog
  • LMT −6.3% on print · execution in focus
  • War premium intact: oil >$100, missile & air-defense pull-through accelerating
Biotech & Pharma
Selective

The week's marquee event was scientific, not financial: Regeneron secured FDA approval for Otarmeni, the first gene therapy targeting an underlying cause of hearing loss and the company's first gene-therapy approval, with no serious adverse events reported in the pivotal trial. Eli Lilly kept the M&A pace torrid with three deals (Profluent, Ajax, Kelonia) totaling up to ~$11.5B, anchoring its AI-discovery and CAR-T pipelines. Merck swung to a Q1 loss of $1.28/sh after a $3.62/sh charge on its Cidara acquisition, underscoring the post-Keytruda runway problem.

  • REGN Otarmeni · first-in-class gene therapy approval
  • LLY ~$11.5B in pipeline M&A in two weeks
  • MRK Q1 loss on Cidara charge · revenue $16.29B beat
  • PFE, VRTX on deck next week

Notable Earnings This Week

Date Ticker Company EPS Act / Est Rev Act / Est Reaction
Wed 4/29 GOOGL Alphabet Beat / Beat Beat +6% AH · capex raise
Wed 4/29 MSFT Microsoft Beat / Beat Beat −3% · capex digestion
Wed 4/29 META Meta Platforms Beat / Beat Beat −5% · flat Q2 guide
Wed 4/29 AMZN Amazon Beat / Beat Beat −3% · AWS in-line
Thu 4/30 AAPL Apple $2.01 / $1.95 $111.2B / $110B +3% · record iPhone, Services
Thu 4/30 MRK Merck ($1.28) / ($1.51) $16.29B / $15.82B Loss on Cidara charge
(Prior wk) RTX RTX Corp. $1.78 / $1.52 $22.1B / $21.45B Guide raise to $6.70–$6.90
(Prior wk) NOC Northrop Grumman $6.14 / $6.06 $9.9B / $9.8B Backlog at $95.7B
(Prior wk) LMT Lockheed Martin Miss / Miss ~$18.0B −6.3% on print

Looking Ahead — Week of May 4–8

// Macro Calendar

A jobs-heavy week. ISM Services (Mon), JOLTS (Tue), ADP (Wed), trade balance and productivity data through midweek, capped by the marquee April nonfarm payrolls release on Friday, May 8. Consensus: payrolls +73k, average hourly earnings +0.3% m/m, unemployment rate 4.3% (unchanged). Preliminary UMich sentiment closes the week. Offshore: rate decisions in Australia, Sweden, Norway and Mexico.

// Earnings Catalysts

The earnings baton passes from mega-cap to second-line AI and consumer. On deck: Palantir, AMD, Arista Networks, Super Micro Computer, Pfizer, McDonald's, PayPal, Disney, Uber, Kraft Heinz, Viatris and Unity Software. AMD's MI450 commentary and the Meta/OpenAI infrastructure deals will set the next leg of the AI-accelerator narrative.

QuantLogix View
We enter May with the Nasdaq at a record, the Fed on hold against a hawkish dissenting bloc, and core PCE pinned at 3.5%. Our base case is that the AI-capex bid persists into AMD/Palantir prints, but breadth must broaden — financials, industrials and select biotech — for the rally to clear a soft payrolls print without a volatility regime shift. Watch the 10Y: a clean break above 4.45% would compress multiples on the most expensive cohort first. Tactically: keep duration short, lean into AI infrastructure with selectivity, fade weakness in defense primes with execution leverage (RTX, NOC), and treat hot oil as both a tail risk and an ongoing tax on consumer sentiment.